Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Nencini

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dental Cadmos|June 1, 1984
[Direct bonding in orthodontics]C Parrini, F Nencini, F Bottai
Allergy|August 14, 2012
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammationA Vultaggio, F Nencini, S Pratesi, et al.
Allergy|December 3, 2009
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactionsA Vultaggio, A Matucci, F Nencini, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2013
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximabA Matucci, S Pratesi, G Petroni, et al.
Allergy|May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolutionA Vultaggio, F Nencini, A Carraresi, et al.
Journal of Investigational Allergology & Clinical Immunology|December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPAS Bormioli, A Vultaggio, F Nencini, et al.
Clinical and Experimental Immunology|August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactionsA Vultaggio, G Petroni, S Pratesi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dental Cadmos|June 1, 1984
[Direct bonding in orthodontics]C Parrini, F Nencini, F Bottai
Allergy|August 14, 2012
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammationA Vultaggio, F Nencini, S Pratesi, et al.
Allergy|December 3, 2009
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactionsA Vultaggio, A Matucci, F Nencini, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 29, 2013
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximabA Matucci, S Pratesi, G Petroni, et al.
Allergy|May 3, 2018
IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolutionA Vultaggio, F Nencini, A Carraresi, et al.
Journal of Investigational Allergology & Clinical Immunology|December 22, 2021
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPAS Bormioli, A Vultaggio, F Nencini, et al.
Clinical and Experimental Immunology|August 30, 2016
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactionsA Vultaggio, G Petroni, S Pratesi, et al.
Pageof 1